Farrens, Andria J.
Reinsdorf, Dylan
Garcia-Fernandez, Luis
Rojas, Raymond Diaz
Chan, Vicky
Perry, Joel
Wolbrecht, Eric T.
Reinkensmeyer, David J.
Funding for this research was provided by:
National Institutes of Health (NCT04818073, NCT04818073, NCT04818073, NCT04818073, NCT04818073, NCT04818073, NCT04818073, NCT04818073)
Article History
Received: 24 December 2024
Accepted: 10 June 2025
First Online: 18 July 2025
Declarations
:
: All participants provided informed consent (UCI IRB#476), and procedures were conducted according to the Declaration of Helsinki. The trial was registered on ClinicalTrials.Gov (NCT04818073).
: Not applicable.
: Dr. David Reinkensmeyer has financial interest (stock and consulting) in Hocoma and Flint Rehabilitation, both rehabilitation device companies.